Figure 3.

Anti-CCA activities indicated by prolongation of survival time (mean ± SEM), of CUR compound and extracts of ZO, AL, PC, and PPF at various dose levels, in comparison with NSS (untreated control) and 5-FU (reference control) in CCA-xenografted nude mice during the 85 days investigation period. Statistically significant difference by ANOVA, followed by post hoc scheffe test: AL-treated group at low dose level vs. control group (p < 0.001). AL-treated group at medium dose level vs. control group (p < 0.001). AL-treated group at high dose level vs. control group (p < 0.001).

Plengsuriyakarn et al. BMC Complementary and Alternative Medicine 2012 12:23   doi:10.1186/1472-6882-12-23
Download authors' original image